Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
scientific article published on 28 April 2016
Author/s
author: Zachary A. Cooper, Jason Roszik, Alexander J. Lazar, Patrick Hwu, Isabella C Glitza, Michael A Davies, Michael T Tetzlaff, Rodabe N Amaria, Jennifer L McQuade, Jennifer Wargo, Roland L Bassett, Wen-Jen Hwu, Adi Diab, Courtney Hudgens, Khalida Wani, Aron Y Joon, Levi A Garraway
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.